Pages that link to "Q73081258"
Jump to navigation
Jump to search
The following pages link to Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model (Q73081258):
Displaying 25 items.
- COX-2 and cancer: a new approach to an old problem (Q28191533) (← links)
- Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer (Q28193375) (← links)
- Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women (Q33319315) (← links)
- Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways (Q33749203) (← links)
- Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice (Q33805554) (← links)
- COX-2 inhibitors for the prevention of breast cancer (Q35572437) (← links)
- Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways (Q35572443) (← links)
- Role of traditional and new biomarkers in breast carcinogenesis. (Q35572905) (← links)
- COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ (Q36694470) (← links)
- Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? (Q36788347) (← links)
- Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27 (Q36919383) (← links)
- Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival (Q37139815) (← links)
- Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells (Q37431170) (← links)
- Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer. (Q37709099) (← links)
- Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines (Q39622863) (← links)
- Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis (Q44527924) (← links)
- Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination (Q45156518) (← links)
- Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies. (Q45980768) (← links)
- HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression. (Q47102448) (← links)
- Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization (Q51310226) (← links)
- Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer (Q51739707) (← links)
- PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. (Q55017802) (← links)
- HPV16 E7 increases COX-2 expression and promotes the proliferation of breast cancer. (Q55365198) (← links)
- Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion (Q64242221) (← links)
- Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial (Q84007319) (← links)